Latest News of SUNL
UK's NICE Says Alzheimer's Disease Drug Kisunla Is Not Cost-Effective
By Forbes |
6 days ago
The UK approved the Alzheimer's drug Kisunla, facing reimbursement challenges due to cost. NICE requires cost-effective benefits for NHS reimbursement. Kisunla targets beta amyloid and tau plaque in t...
Solar Cells That Work Without Sunlight Open Way For Self-Powered Devices
By Forbes |
1 week ago
Exeger, a Swedish company, has developed solar cells that can generate power from indoor light sources. Their innovative Powerfoyle cells are integrated into various products, reducing the need for di...
Lilly's Kisunla does not demonstrate "good value" for UK's NHS
By Yahoo! Finance |
2 weeks ago
Eli Lilly's Alzheimer's drug, Kisunla, faces NICE rejection in the UK due to concerns about cost-effectiveness and uncertainties about long-term benefits. The drug, like Leqembi, targets amyloid plaqu...
-
Tesla's self-driving cars investigated over safety in fog and bright sunlight
By Yahoo! Finance | 3 weeks agoUS authorities are investigating Tesla vehicles after reports of crashes in self-driving mode due to poor visibility. Tesla's reliance on cameras and AI software is questioned. The company's autonomou...
-
Eli Lilly Gets Japan OK for Kisunla Alzheimer's Disease Drug
By MarketWatch | 1 month agoEli Lilly's Kisunla has been approved in Japan for early symptomatic Alzheimer's. The drug, also approved in the US, is an antibody given as a monthly infusion that has shown to slow the progression o...
-
Victim shot in a Sunland Jack in the Box restroom, suspect holed up in a liquor store
By CBS News | 2 months agoA suspect who shot a person at a Jack in the Box in Sunland is now holed up in a nearby liquor store, as police have surrounded the area. The victim, a 35-year-old man, sustained non-life-threatening ...
-
Council Post: From Spotlight To Sunlight: How To Prioritize LGBTQIA+ Inclusivity Year-Round
By Forbes | 3 months agoAntoine Andrews, Chief Diversity & Social Impact Officer at SurveyMonkey, stresses the importance of year-round support for the LGBTQIA+ community, urging organizations to move beyond performative ges...
-
FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
By Yahoo! Finance | 4 months agoEli Lilly's drug Kisunla, approved by the FDA for early symptomatic Alzheimer's, showed promising results in slowing disease progression. Despite obstacles, including delays, the drug is set to compet...
-
FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla
By USA Today | 4 months agoAn FDA panel recommended the approval of a new Alzheimer's drug, donanemab, which slows cognitive decline. The drug, marketed as Kisunla, removes beta-amyloid plaques in the brain....